Form 4: Verizon Executive Kyle Malady Sells 9,000 Shares of Common Stock
SEC Filing Form 4
EVP and Group CEO of Verizon Business, Kyle Malady, disposed of 9,000 shares of Verizon Communications Inc. common stock at an average price of $44.1 per share on May 7, 2025.
Summary
- On May 7, 2025, Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., sold 9,000 shares of common stock.
- The shares were sold at a weighted average price of $44.1, with individual transactions ranging from $44.095 to $44.112 per share.
- Following the transaction, Malady directly owns 10,008 shares and indirectly owns 18,692 shares through a 401(k).
- The sale was reported on a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of an executive stock sale. The size of the sale is not significant enough to indicate strong positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence and are often scrutinized by investors for insights into management's perspective on the company's future prospects. However, without additional context, it's difficult to determine the specific reasons behind this sale.
Comparison to Industry Standards
- Executive compensation and stock ownership are closely monitored across the telecommunications industry.
- Comparing Kyle Malady's stock transactions and ownership levels with those of executives at companies like AT&T (T) and T-Mobile (TMUS) could provide a benchmark for assessing the significance of this sale.
- Analyzing the timing and size of insider transactions relative to company performance and industry trends is a common practice in financial analysis.
Stakeholder Impact
- The stock sale could have a minor impact on shareholder sentiment, depending on how it's perceived by the market.
- The transaction itself does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/07/2025 | Date of transaction: Sale of 9,000 shares of Verizon common stock. |
| 05/08/2025 | Date of report filing. |
Keywords
Form 4, Verizon, Stock Sale, Kyle Malady, VZ, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.